OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Therapies for Kidney Disease in People With Diabetes
Nayana Khurana, Steven James, Melinda T. Coughlan, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. e1-e24
Open Access | Times Cited: 16

Showing 16 citing articles:

The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management
Mahendra Kumar, Shah Dev, Muhammad Khalid, et al.
Cureus (2023)
Open Access | Times Cited: 34

Metabolic syndrome — a new definition and management guidelines
Piotr Dobrowolski, Aleksander Prejbisz, Alina Kuryłowicz, et al.
Arterial Hypertension (2022) Vol. 26, Iss. 3, pp. 99-121
Open Access | Times Cited: 24

Effects of Vitamin D Supplementation in Diabetic Kidney Disease: A Systematic Review
T.D. Ullmann, Beatrys Juliani Ramalho, Lucas Fornari Laurindo, et al.
Journal of Renal Nutrition (2023) Vol. 33, Iss. 5, pp. 618-628
Closed Access | Times Cited: 10

Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy
Danfeng Liu, Xiaojie Chen, Weiting He, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 4
Closed Access | Times Cited: 3

Circular RNAs: An emerging precise weapon for diabetic nephropathy diagnosis and therapy
Haiying Shu, Zhen Zhang, Jieting Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115818-115818
Open Access | Times Cited: 6

Glucagon‐like peptide‐1 receptor agonists and kidney outcomes
Richard J. MacIsaac, Philippa Trevella, Elif I. Ekinci
Journal of Diabetes (2024) Vol. 16, Iss. 10
Open Access | Times Cited: 1

Comprehensive insights into diabetic nephropathy: pathophysiology, clinical features, and emerging treatments
Mounira Habli
Journal of The Egyptian Society of Nephrology and Transplantation (2024) Vol. 24, Iss. 4, pp. 163-168
Closed Access | Times Cited: 1

Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease
Rajesh Raj
Current Opinion in Nephrology & Hypertension (2022) Vol. 31, Iss. 3, pp. 265-271
Closed Access | Times Cited: 6

Effects of Fenofibrate and Gemfibrozil on Kynurenic Acid Production in Rat Kidneys In Vitro: Old Drugs, New Properties
Izabela Zakrocka, Tomasz Kocki, Ewa M. Urbańska, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2154-2154
Open Access | Times Cited: 2

Effect of Atorvastatin combined with Irbesartan in the treatment of early diabetic nephropathy
Xiaojing Zhong, Jiajia Fan
Pakistan Journal of Medical Sciences (2024) Vol. 40, Iss. 7
Open Access

Effect of fenofibrate and gemfibrozil on kynurenic acid production in rat kidney in vitro: old drugs, new possibilities
Izabela Zakrocka, Wojciech Załuska
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

Insights Into the Functional Mechanism of Diabetic Kidney Disease Treatment with Sinensetin Based on Network Pharmacology and Molecular Docking
Ruhong Zhou, Qi Wu, Xufang Wang, et al.
Integrative Medicine in Nephrology and Andrology (2023) Vol. 10, Iss. 4
Closed Access | Times Cited: 1

Probucol will become a new model for treating cerebral infarction with a high risk of hemorrhage: A narrative review
Liguo Lang, Jianying Zhang, Dongju Zheng, et al.
Brain Circulation (2023) Vol. 9, Iss. 4, pp. 222-227
Open Access | Times Cited: 1

Page 1

Scroll to top